Development of Long COVID: New Symptoms and Risk Factors Identified – The Cardiology Advisor

General Medicine
Development of long COVID correlated independently with 62 different symptoms across multiple organ systems as well as several sociodemographic and clinical risk factors, according to study findings published in Nature Medicine.
Researchers conducted a population-based, retrospective, matched-cohort study in the United Kingdom from January 31, 2020 and April 15, 2021 to improve understanding of risk factors associated with long COVID development. They collected data on nonhospitalized patients who experienced symptoms consistent with long COVID at least 3 months after onset of acute COVID-19 infection from the Clinical Practice Research Datalink (CPRD) Aurum.
During this study period, 486,149 nonhospitalized adults had confirmed COVID-19 infection, while 8,030,224 people did not have records of confirmed or suspected COVID-19 infection.
After 3 months, 62 symptoms significantly correlated with COVID-19 infection, especially the following:
Of the 486,149 nonhospitalized adults with confirmed COVID-19, 384,137 had a minimum of 12 weeks of follow-up, and 20,864 (5.4%) reported at least 1 long COVID symptom.
The researchers performed propensity-score matching, selecting 1,944,580 people of the 8,030,224 people without recorded COVID-19 infection. Only 1,501,689 participants in this cohort had a minimum of 12-weeks of follow-up, and 65,293 (4.3%) reported at least 1 long COVID symptom.
The researchers observed several risk factors for developing long COVID, including:
They also observed various comorbidities as risk factors for long COVID, including, but not limited to:
Long COVID occurred more frequently among people of minority ethnicities and along a gradient of decreasing age with people between the ages of 18 and 30 demonstrating increased risk of developing long COVID.
“Infection with [COVID-19] is independently associated with the reporting of 62 symptoms spanning multiple organ systems 12 weeks or longer after infection,” the researchers stated. “A wide range of both sociodemographic and clinical factors are independently associated with development of persistent symptoms.”
Study limitations included potential misclassification bias, lack of true representation of long COVID burden based solely on coded health care data secondary to decreased encounters with primary care providers during the pandemic, potential underreporting by patients, and the inability of the researchers to investigate all aspects of long COVID, particularly impact on daily functioning.
This article originally appeared on Neurology Advisor

Continuing Medical Education (CME/CE) Courses
Show More
Please login or register first to view this content.

Copyright © 2022 Haymarket Media, Inc. All Rights Reserved
This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.
Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions.
Looks like you’re enjoying our content…
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. Read an unlimited amount by logging in or registering at no cost.
{{login-button}} {{register-button}}
Get the most out of Cardiology Advisor.
Register for free and enjoy unlimited access to:
– Clinical News
– Case Studies
– Conference Coverage
– Full-Length Features
– Drug Monographs
– And More
{{login-button}} {{register-button}}
Please login or register first to view this content.


Leave a Reply

Your email address will not be published.